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Background: Traumatic spinal cord injury (SCI)-induced overproduction of endogenous deleterious substances
triggers secondary cell death to spread damage beyond the initial injury site. Substantial experimental evidence
supports reactive species (RS) as important mediators of secondary cell death after SCI. This study established
quantitative temporal and spatial profiles of cell loss, characterized apoptosis, and evaluated the effectiveness of a
broad spectrum RS scavenger - Mn (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) and a combination of MnTBAP
plus nitro-L-arginine to prevent cell loss and neurological dysfunction following contusion SCI to the rat spinal cord.
Results: By counting the number of surviving cells in spinal cord sections removed at 1, 6, 12, 24, 48, 72 h and
1 week post-SCI and at 0 – 4 mm from the epicenter, the temporal and spatial profiles of motoneuron and glia loss
were established. Motoneurons continued to disappear over a week and the losses decreased with increasing
distance from the epicenter. Significant glia loss peaked at 24 to 48 h post-SCI, but only at sections 0–1.5 mm from
the epicenter. Apoptosis of neurons, motoneurons and astrocytes was characterized morphologically by double
immuno-staining with cell-specific markers and apoptosis indicators and confirmed by transmission electron
microscopy. DNA laddering, ELISA quantitation and caspase-3 activation in the spinal cord tissue indicated more
intense DNA fragments and greater caspase-3 activation in the epicenter than at 1 and 2 cm away from the
epicenter or the sham-operated sections. Intraperitoneal treatment with MnTBAP + nitro-L-arginine significantly
reduced motoneuron and cell loss and apoptosis in the gray and white matter compared with the vehicle-treated
group. MnTBAP alone significantly reduced the number of apoptotic cells and improved functional recovery as
evaluated by three behavioral tests.
Conclusions: Our temporal and spatial profiles of cell loss provide data bases for determining the time and
location for pharmacological intervention. Our demonstration that apoptosis follows SCI and that MnTBAP alone or
MnTBAP + nitro-L-arginine significantly reduces apoptosis correlates SCI-induced apoptosis with RS overproduction.
MnTBAP significantly improved functional recovery, which strongly supports the important role of antioxidant
therapy in treating SCI and the candidacy of MnTBAP for such treatment.
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Spinal cord injury (SCI) develops in two phases: primary
injury and secondary injury. The initial mechanical in-
jury not only directly kills cells and destroys various ele-
ments of the tissue, but also induces overproduction of
endogenous deleterious substances, which trigger sec-
ondary damage processes that lead to secondary cell
death, thereby spreading damage beyond the initial in-
jury site [1,2]. Apoptosis is an important contributor to
secondary cell death after SCI. Numerous studies have
shown that neuronal and glial apoptosis follows SCI
[3-6]. Cells die by necrosis or apoptosis depending on
the types and concentrations of the triggering death sig-
nals. At the injury epicenter, the concentration of en-
dogenous deleterious substances produced upon the
initial trauma reaches a maximum, and then gradually
declines with distance from the epicenter; in like man-
ner, the type of cell death may also depend on the dis-
tance from the injury epicenter. Therefore, it is critical
to explore the temporal and spatial profiles of cell death
by necrosis and apoptosis for each type of cell to pre-
cisely define the time window and the damage area for
therapeutic intervention.
Reactive species (RS), including free radicals and non-
radical oxidants, are believed to contribute to secondary
destruction after central nervous system (CNS) injury by
oxidatively damaging the major cellular components
proteins: DNA, and phospholipids [7-9]. Substantial ex-
perimental evidence supports RS as important mediators
of secondary damage after SCI [10-13]. We and others
have demonstrated that the levels of superoxide anion
[6,14], hydrogen peroxide [15], hydroxyl radical [16],
catalytic iron [17], nitric oxide (•NO) [18,19] and peroxy-
nitrite [18,20], as well as the products of oxidation and
nitration of proteins [6,18,21-23] and membrane lipid
peroxidation (MLP) [24-26], all significantly increase fol-
lowing SCI. By administering the increased levels of RS
into an un-injured rat spinal cord, we demonstrated that
they caused oxidative damage to major cellular compo-
nents [27,28], neuronal death by necrosis and apoptosis
[29-31] and neurological dysfunction [29]. Our in vivo
demonstration unequivocally links SCI-induced RS ele-
vation to necrotic and apoptotic cell death and neuro-
logical dysfunction in SCI. Therefore, a broad spectrum
scavenger of RS should more effectively reduce secon-
dary cell death and the resulting neurological dysfunc-
tion than would agents with a single target.
Metalloporphyrins, a novel class of catalytic antioxidants,
not only scavenge a wide range of RS such as superoxide
anion, hydrogen peroxide, peroxynitrite and lipid peroxyl
radicals [32], but also modulate RS-based redox signaling
pathways [33]. The metalloporphyrin Mn (III) tetrakis
(4-benzoic acid) porphyrin (MnTBAP) possesses both
superoxide dismutase and catalase-like activity [34] andscavenges peroxynitrite [35]. It is also a potent inhibitor of
MLP [36]. In the CNS, cerebroventricular injection of
MnTBAP inhibited kainate-induced mitochondrial super-
oxide production, DNA oxidation and neuronal loss in the
hippocampus of rat [37]. We demonstrated in vivo that
MnTBAP reduced peroxynitrite-induced oxidation and ni-
tration of proteins [27] and MLP [28] in the rat spinal cord.
It prevented hydroxyl radical-induced necrotic and apop-
totic cell death [31]. We recently demonstrated that intra-
thecal administration of MnTBAP reduced superoxide and
hydrogen peroxide production, reduced oxidation and ni-
tration of proteins and increased the number of surviving
neurons, motoneurons, astrocytes and oligodendrocytes
after SCI [38-40]. These results suggest that the catalytic
antioxidant MnTBAP may be a potential agent for anti-
oxidant therapy, owing to its cell permeability, low toxicity
and broad scavenging of RS.
However, MnTBAP was reported poorly able to pene-
trate the blood–brain barrier [41], so it does not seem to
be a favorable candidate for antioxidant therapy for CNS
injury and degenerative disorders. We compared the
penetrating ability of MnTBAP to methylprednisolone
(MP), the only drug used clinically to treat SCI. We
found that, despite the much lower penetration of the
blood-spinal cord barrier (BSB) by MnTBAP compared
with MP, its higher stability allows a lower dose of
MnTBAP to produce a higher concentration in the CSF
than does higher doses of MP [42]. Moreover, we de-
monstrated that MnTBAP (10 mg/kg) given intrape-
ritoneally (i.p.) increased the number of neurons and
attenuated the number of apoptotic neurons after SCI
[43]. Treatment with this dose of MnTBAP (i.p.) more
effectively improved the functional recovery after SCI
than did the standard MP regimen [40]. These results
suggest that MnTBAP indeed crossed the BSB and
reached the appropriate targets, perhaps in part, because
the injury disrupted the BSB to allow MnTBAP to pass
through. Therefore, MnTBAP warrants further exami-
nation of its antioxidative efficacy.
In our previous study, we established the temporal and
spatial profile of neuron death, the temporal and spatial
profiles of the appearance of apoptotic cells in the gray
and white matter and the temporal and spatial profiles
of neuronal apoptosis after SCI [43]. The goals of the
present study were the following. 1) To established the
temporal and spatial profiles of glial cell loss in the white
matter and motoneuron loss in the gray matter for up
to one week following severe injury to the rat lumbar
enlargement. 2) To characterize SCI-induced apoptosis
of neurons, motoneurons and glial cells morphologically
and biochemically. 3) To evaluate the efficacy of cell pro-
tection by MnTBAP and a combination of MnTBAP plus
nitro-L-arginine (L-NA) ― a non-selective nitric oxide
synthase (NOS) inhibitor. It was reported that MnTBAP
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•NO occurs when it reacts with overproduced superoxide
to form peroxynitrite - a strong oxidant, whereas MnTBAP
scavenges peroxynitrite. Therefore, both MnTBAP alone
and the combination of MnTBAP+ L-NA will be tested for
their protection against cell loss following SCI. 4) To test
the ability of MnTBAP to improve functional recovery after
SCI by behavioral tests. Accomplishment of these goals will
provide a foundation for determining the optimal time and
location to test the therapeutic potential of pharmaceutical
agents to prevent cell death and apoptosis and add new
information for exploring the therapeutic potential of the
catalyst antioxidant MnTBAP in SCI treatment.
Methods
All animal experimental procedures were approved by
the University of Texas Medical Branch Animal Care
and Use Committee and were in accord with the NIH
Guide for the Care and Use of Laboratory Animals.
Establishing cell loss profiles and characterizing cellular
apoptosis morphologically following SCI
Animal preparation, spinal cord injury and drug
administration
To obtain the temporal and spatial profiles of cell loss
after SCI, male Sprague–Dawley rats (250–300 g) were
randomly divided into two groups: injured and sham op-
erated. Animals were anesthetized with pentobarbital
(50 mg/kg, i.p.). When the rat was fully anesthetized, a
laminectomy was performed on vertebra T13 and the
dura was kept intact. Care was taken not to injure the
cord. Then the animal was clamped in a frame by at-
tachments to its dorsal vertebral processes. The cord
was injured severely by dropping a weight (10 g) through
a guide tube 5 cm onto the cord (50 g.cm) according
to the impact method originally devised by Allen [45]
and modified by us. The weight was fitted with a Teflon
tip with an area of 10 mm2. After injury, the incision
was surgically repaired and the rats were housed in a
temperature- and humidity-controlled room with a 12 h
light/dark cycle. Animals had free access to food and
water. The procedures for anesthesia, surgery and impact
injury are described in detail in our previous publications
[14-18,21]. The only difference in animal preparation be-
tween the sham-operated control and the injured group
was that no impact injury was performed in the sham rats.
To test the protection against cell death by the combin-
ation of MnTBAP (Calbiochem, San Diego, CA, USA) and
L-NA, the animal was injured as above, then MnTBAP
(10 mg/kg) plus L-NA (1 mg/kg) dissolved in saline was
given i.p. at 15 min pre- and 6 h post-SCI. To obtain the
spatial profiles of MnTBAP protection against apoptotic
cell death, MnTBAP alone (10 mg/kg in saline) was ad-
ministered by i.p. injection as described above. In thevehicle control group, animals were injured and saline was
administered as in the treated group.
Spinal cord tissue processing for morphological examination
To establish the temporal and spatial profiles of moto-
neuron and glial cell loss, the injured cords were harvested
at 1, 6, 12, 24, 48, 72 h and 1 week post-SCI as the same
time points as for establishing the temporal and spatial
profile of neuron loss [43], so the profiles of different
cell types can be compared. At the time of cord removal,
the animals were re-anesthetized with pentobarbital
(50 mg/kg), perfused intracardially with 0.9% saline,
followed by 4% paraformaldehyde in 0.1 M phosphate-
buffered saline (PBS, pH 7.2-7.4) while the animal was
still deeply anesthetized. A second laminectomy was
performed on vertebrae T11-L3 to extend the exposed
cord, so that segments approximately 1.5 cm long cen-
tered at the injury site were removed and fixed in the
same fixative overnight and embedded in paraffin. Rats
that served as sham-operated controls were similarly
perfused at 12 h post-operation. Serial sections (10 μm
thick) were cut and mounted on glass slides coated with
poly-L-lysine.
The sections at 0.1 mm (10 sections) intervals from every
cord were deparaffinized and stained histochemically with
cresyl violet (CV) as describe in our previous publications
[31]. The CV-stained sections were observed under a light
microscope to locate the epicenter (with the lowest cell
density). After the epicenter was determined, the spinal
sections at 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 and 4.0 mm cau-
dal from the epicenter at each time point post-SCI were
CV-stained to obtain the temporal and spatial profiles of
cell death.
From our temporal and spatial profiles, we found that
severe neuron [43] and motoneuron loss near the epi-
center starting at 12 and 24 h post-SCI and gradually
spread to longer distance over time. Our temporal and
spatial profiles of apoptosis published previously [43], in-
dicated that the peak time of TUNEL-positive cell ap-
pearances are from 12 to 48 h post-SCI. Therefore, 12 to
48 h post-SCI is a reasonable time frame in which to
evaluate the efficiency of treatment to reduce cell death
and apoptosis. The rostral sections removed at 12 h
post-SCI at 0–4.0 mm from the epicenter were also CV-
stained to be used as vehicle controls to establish the
spatial profile of MnTBAP + L-NA protection against
cell death and for terminal deoxynucleotidyl transferase
(TdT)-mediated deoxyuridine triphosphate-(dUTP)-bio-
tin nick end labeling (TUNEL) staining to evaluate the
protection of the combined treatment against apoptosis.
The rostral sections obtained at 24 h post-SCI at 0, 1.0,
2.0 and 4.0 mm from the epicenter were used for TUNEL
staining as vehicle-treated group to evaluate MnTBAP pro-
tection against apoptotic cell death and for characterization
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injured spinal cord in the MnTBAP + L-NA-treated rats
was removed at 12 h post-SCI and the injured cord in the
MnTBAP-treated rats was removed at 24 h post-SCI.
TUNEL staining and TUNEL plus immunohistochemical or
immuno-fluorescence double staining to characterize apop-
tosis in different types of cells in injured spinal sections
DNA fragmentation in the nuclei is an indicator of apop-
tosis. Fragmented DNA in the nuclei of cells was charac-
terized by TUNEL staining using an ApopoTag peroxidase
in situ apoptosis detection kit according to the manufac-
turer’s instructions. The TUNEL staining and visualization
of spinal cord sections were performed according to pro-
cedures we previously reported [30,31,43]. The only diffe-
rence was that, in the present study, the TUNEL detecting
kit was purchased from Millipore (Billerica, MA, USA).
Nonspecific labeling was investigated by using water or
equilibration buffer to substitute for the volume of TdT in
the TUNEL reaction mixture.
To characterize apoptosis in different types of cells,
TUNEL plus immunohistochemical double staining was
performed. The spinal cord sections were first stained
with TUNEL, then stained with antibodies specific to
different types of cells. Following TUNEL staining, the
sections were washed in three changes of PBS for 5 min
each, blocked with 5% goat serum and incubated with:
a mouse monoclonal antibody directed against neuron spe-
cific enolase (NSE, 1:100, DAKO, Carpinteria, CA, USA)
to stain neurons; a rabbit polyclonal antibody directed
against choline acetyltransferase (ChAT, 1:500, Abcam,
Cambridge, UK) to stain motoneurons; or a monoclonal
antibody against glial fibrillary acidic protein (GFAP, 1:200,
Sigma, St. Louis, MO, USA) to stain astrocytes. After
washing in PBS, the sections were incubated with bio-
tinylated goat anti-rabbit-IgG (1:200, Sigma, St. Louis,
MO, USA) or goat anti-mouse-IgG (1:200, Sigma, St. Louis,
MO, USA) followed by a solution of an avidin-biotin-
horseradish peroxidase complex (1:200, Vector Laborato-
ries, Inc., Burlingame, CA, USA). The sections were then
visualized with SG Substrate Kit (Vector Laboratories,
Inc., Burlingame, CA, USA), washed in water, dehydrated,
cleaned and coverslipped with Permount as described in
our previous report [30,31,43]. Negative controls were
similarly stained without the primary antibody.
Motoneurons were also characterized with TUNEL
and immuno-fluorescence double staining. The TUNEL
staining was performed similarly as above, but using the
ApopTag plus fluorescein In Situ apoptosis detection kit
(Chemicon Intl. Temecula, CA, USA) following the
manufacturer’s instruction. After TUNEL staining, the
sections were immuno-stained as in the above proce-
dures with the primary antibody, mouse anti-ChAT
(1:100, ABcam, Cambridge, MA, USA). After washing inPBS for 3 times, a secondary antibody goat anti-mouse
Alexa Flour 594 (Invitrogen, Carlsbad, CA, USA) was
added to the sections and the sections were incubated
for 1 h at room temperature. The sections were washed
in PBS and coversliped with anti-fade solution (Invitro-
gen) and kept in the dark. Negative controls were simi-
larly stained without the primary antibody.
Active caspase-3 and cellular marker immuno-fluorescence
double staining
Caspase-3 activation is another indicator of apoptosis.
To characterize apoptosis in different types of cells,
double immuno-fluorescence staining with antibodies
against active caspase-3 and specific cellular markers was
performed. The procedures for immuno-fluorescence
staining were similar to those described above. The depar-
affinized spinal cord sections were rinsed in PBS and
placed in 5% goat serum in PBS for 30 min, then incu-
bated with the primary antibody: a monoclonal antibody
anti-NSE (1:100, DAKO, Carpinteria, CA, USA) or a
monoclonal antibody anti-GFAP (1:200, Sigma, St. Louis,
MO, USA) to stain neurons or astrocytes, respectively. For
immunohistochemical staining of active caspase-3, the
immuno-stained sections were incubated with the sec-
ondary antibody, a polyclonal antibody anti-p20 active
fragment of caspase-3 (1:200, R&D systems, Inc. Min-
neapolis, MN) in PBS with 0.2% Triton X-100 and 0.1%
bovine serum albumin overnight at 4°C. For visua-
lization, after washing in PBS, the sections were incu-
bated with fluorescein isothiocyanate (FITC)-labeled
goat anti-mouse IgG (1:100, Sigma, St. Louis, MO,
USA) and crystalline tetramethylrhodamine isothio-
cyanate (TRITC)-labeled goat anti-rabbit IgG (1:100,
Sigma, St. Louis, MO, USA) in PBS with 0.2% Triton
X-100 and 0.1% BSA for 1 hour in the dark to visualize
cells and active caspase-3, respectively. The slides were
coverslipped with PBS/glycerol and stored at 4°C after
washing with PBS in the dark. The FITC-labeled neu-
rons or astrocytes display green and the TRITC-labeled
activated caspase-3 displays red fluorescence. Negative
controls were similarly stained without the primary
antibody.
Confirmation of apoptosis by transmission electron
microscopy (TEM)
For TEM examination of neuronal and glial apoptosis, the
animal preparation and spinal cord injury were done as
described above. At 24 h post-SCI, the rat was perfused
intracardially with 0.9% saline, followed by 4% paraformal-
dehyde with 2.0% glutaraldehyde in 0.01 M PBS (pH 7.4).
After perfusion, the spinal cord was further exposed and a
1.5 cm segment centered at the injury site was removed as
described above and fixed in the same fixative overnight.
Then, the segment was fixed with 4% osmium tetroxide in
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resin. Semi-thin (1 μm) plastic sections at 2-2.5 mm from
the epicenter were cut and stained with 1% toluidine blue
to screen for apoptotic neurons under the light micro-
scope. Ultrathin sections (in the Rexed lamina VIII, gold
interference color) were cut with an ultramicrotome,
stained with uranyl acetate and lead citrate, then exa-
mined using a Hitachi H600 electron microscope (Tokyo,
Japan).
Quantitation of cell loss and apoptosis by counting
surviving or TUNEL-positive cells in spinal cord sections
Surviving cells in the CV-stained sections or TUNEL-
positive cells in the TUNEL-stained sections were
counted in an area of the bottom left and bottom right
quarter of the gray matter of the cord. Quarters were
defined by horizontal and vertical crossed lines drawn
through the central canal in the center of the sections
[18,38-40,43]. This area of gray matter includes moto-
neurons, middle- and small-sized neurons, and glial cells.
Neurons in the CV-stained sections were identified by the
presence of bright nuclei with nucleolus and enrichment in
Nissl bodies. Neurons with soma diameters greater than
25 μm were identified and counted as motor neurons [46].
Glial cells in the CV-stained sections were counted in
250 × 250 μm2 areas of the left and right ventromedial
white matter. TUNEL-positive cells were identified by
dark nuclei and were counted in TUNEL-stained sec-
tions. The cells in the left or right quarters of each sec-
tion were counted 3 times and the counts averaged.
Then, the average counts of the left and right quarters
in each section were averaged to obtain the final counts
for that section. Three adjacent sections were counted
and the counts averaged to obtain the final counts for
that distance. To avoid bias, the person processing the
cord into sections and the person counting the cells in
the sections were blinded. This counting method has been
validated by our previous publications [18,38-40,43] and
by those of many others.
Biochemical characterization and quantification of
apoptosis in spinal cord tissues following SCI
Animal preparation and tissue processing
The animal preparation and impact injury were the same as
described above. At 48 h post-SCI (or post-laminectomy
for sham controls), the animal was re-anesthetized and the
cord was further exposed from the vertebrae T10 to L5 by
a second laminectomy. A cavity was formed by pulling up
the skin around the exposed cord and the spinal cord was
frozen in situ by pouring liquid nitrogen (−196°C) into the
cavity as described previously [21]. The frozen tissue was
cut into three sections of equal length (1 cm each) with
section 1 centered at the epicenter and sections 2 and 3
centered at 1 and 2 cm caudal to the epicenter. Thesections were immediately stored in a −80°C freezer for
characterization of specific laddering of DNA fragments by
agarose gel electrophoresis and for quantitation by enzyme-
linked immuno-sorbent assay (ELISA). Since caspase-3 acti-
vates as early as 4 h post-SCI [6], to analyze caspase-3 acti-
vity, the frozen tissue was removed at 4 h post-SCI. The
cord was cut into 2 sections (1 cm each) with section 1 cen-
tered at the epicenter and section 2 centered 1 cm from
the epicenter.DNA laddering by agarose gel electrophoresis
DNA fragmentation was characterized by radio-end
labeling using [32P]dCTP and agarose gel electrophoresis
following procedures reported [47]. Briefly, the spinal
cord sections were removed and divided at 48 h post-
SCI (5–10 mg wet weight), then gently disrupted with a
hand-operated glass/glass Dounce homogenizer in lysis
buffer (5 mM Tris–HCl, pH 7.4, containing 0.5% Triton
X-100, 1:15 w:v), left on ice for 20 min, centrifuged for
30 min at 4°C at 15,000 g to remove the nuclei and cel-
lular debris, then extracted with phenol:chloroform:-
isoamyl alcohol (25:24:1). After centrifugation, DNA in
the aqueous phase was precipitated using ethanol. The
DNA pellet was resuspended in 20 μl of Tris-EDTA buffer
(pH 8.0) and treated with 20 μg/ml RNase A for 1 h at 37°C
to digest the RNA. After quantitation, 2 μg of DNA from
each sample was labeled with [32P]dCTP (50 μCi) by the
standard method involving the Klenow fragment of DNA
polymerase I. Samples were then re-extracted as above to
remove unincorporated nucleotides, resuspended in DNA
gel loading buffer and loaded onto a 2% agarose gel. After
electrophoresis, the gel was dried under vacuum and
exposed for 24 h to autoradiographic film.Quantitation of DNA fragmentation by ELISA
Frozen spinal cord removed at 48 h post-injury was
homogenized in lysis buffer containing 8 M urea, 0.24 M
sodium phosphate, 1% sodium dodecyl sulfate and 10 mM
EDTA, pH 6.8 using a 20:1 solution to tissue ratio (v:w).
The homogenates were extracted with an equal volume
of phenol-chloroform-isoamyl alcohol (25:24:1) satu-
rated with the homogenization buffer. The resulting
emulsion was separated into two phases by centrifu-
gation at 4,500 g for 3 min in an Eppendorf centrifuge.
The aqueous phase above the organic phase was removed
for DNA analysis as reported originally by Beland and co-
workers [48] and slightly modified by us [21]. Aliquots
(10 μl) of each sample were used to quantitate the
nucleosome-associated apoptotic DNA fragments by
ELISA using a commercial cell death detection kit
(Boehringer Mannheim, Indianapolis, IN, USA) which
detects histone-associated DNA fragments enriched in
the cytoplasm of a dying cell. The analysis was
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Analysis of caspase-3-like protease activity
Caspase-3-like protease activity was measured according
to the reported procedure [49,50]. Briefly, approxi-
mately 40 mg of spinal cord tissue was homogenized in
a 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buffer (pH 7.5) containing 1 mM ethylene
glycol-bis (β-aminoethyl ether) N,N,N’,N’-tetraacetic acid,
5 mM MgCl2, 1 mM phenylmethyl-sulphonyl fluoride
and 1 μg/ml leupetin and aprotinin, then centrifuged at
12,000 g for 15 min. The protein concentration in the
supernatant was detected using the Bio-Rad Protein
Assay kit (Bio-Rad Laboratories, Hercules, CA, USA).
Then, 75 μg protein was incubated with synthetic fluo-
rescent substrates benzyloxycarbonyl-Asp-Glu-Val-Asp-
7-amino-4-trifluoromethylcoumarin (Z-DEVD-AFC, Enzyme
Systems Products, Livermore, CA, USA) to assay the
caspase-3-like protease activity at a concentration of
50 μM in 300 μl of 0.1 M HEPES buffer (pH 7.4) at 37°C
for 1 h. The HEPES buffer contains 2 mM dithiothreitol,
0.1% CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-
1-propane-sulfonate) and 10% sucrose. DEVD-AFC clea-
vage was measured using a spectrafluorimetric detector
(Shimadzu RF-10A, Shimadzu Europa GmbH, Duisburg,
Germany) at an excitation wavelength of 400 nm and an
emission wavelength of 505 nm. The fluorescence inten-
sity was calibrated with a standard concentration of AFC
and expressed in pmol per minute per mg of protein.
Behavioral assessments
The protective effect of MnTBAP on the functional
recovery after SCI was assessed by the Basso-Beattie-
Bresnahan locomotor rating scale (BBB test), the in-
clined plane test, and the beam walk test for 9 weeks.
SCI causes hind limb paralysis and inability of the rat
to support its body weight, so the scrotum of male rats
touched and dragged around the bottom of cage, in-
creasing the incidence of infection. Therefore, most
publications using behavioral tests to study SCI use fe-
male rats. This study examined the efficacy of MnTBAP
to attenuate neurological deficits in three groups of fe-
male rats (200–225 g): injured groups treated with saline
or MnTBAP (n = 8 for injured groups) and sham-operated
controls (n = 4).
The injuries for behavioral tests to evaluate functional
recovery after SCI are performed on T9 or T10 by using
the standard New York University (NYU) weight drop
device [40,51,52] or the Infinite Horizons (IH, Lexington,
KY) device [53-55] in many publications. To explore the
therapeutic potential of MnTBAP in treating SCI by be-
havioral tests, in the present study, the cord was injured
on vertebra T10 using the NYU device, so that theresults can be compared with other publications using
behavioral tests.
Animal preparation, impact injury and drug administration
The rats were given 0.1 mg/kg buprenorphine subcutane-
ously (s.c.) 15 min prior to anesthesia, then anesthetized
with pentobarbital (50 mg/kg, i.p.). After a laminectomy,
the exposed cords were injured on vertebra T10 by a 10 g
rod dropping 1.25 cm onto the exposed cord (12.5 g.cm
force) using NYU device. Then, the muscle and skin were
sutured in layers and 10 ml saline was injected (i.p.) to
prevent dehydration. The body temperature of the rat was
maintained using a feedback-controlled heating pad du-
ring surgery and until the animal awoke from surgery.
MnTBAP (10 mg/kg) or saline was given by i.p. injection
15 min pre- and 4 h post-SCI for behavioral tests. In the
sham-operated control group, animals underwent the
same surgical procedures but no weight drop injury was
performed. These rats were housed in a temperature- and
humidity-controlled room with a 12 h light/dark cycle.
In the first week following SCI, the bladder was emptied
manually until the voiding reflex was recovered; bupre-
norphrine (0.5 mg/kg, s.c.) was given post-injury to
minimize the impairment or discomfort of injured rats.
The body weight of the animal was monitored during
behavioral tests. If the loss of body weight was more
than 20% pre-injury weight, the animal was terminated.
Since only the hindlimbs were paralyzed, the rat could still
reach food and water. All experiments were triple blinded:
2 blinded observers gave scores and the third one admi-
nistered MnTBAP or vehicle, blinded to the 2 observers.
BBB test
The motor function of rats was assessed using the BBB
locomotor rating scale as reported [56,57]. The test is
designed to assess progressive locomotor recovery after
SCI. The BBB score was assessed by observing each ani-
mal walking in an open field for 4 min. The open field
was simply a molded plastic pool with a dimpled floor
(100 cm diameter, 21 cm height). To observe animal
locomotion requires pretest training. Before surgery, the
rats were exposed to the testing environment twice a
day for 5 days. Each rat was handled several times dur-
ing each 30–60 min session so that they no longer
showed signs of fear and became accustomed to being
picked up and walking continuously in the open field en-
vironment. Then the rats were individually placed in the
open field for 4 min to assure that all consistently ob-
tained a maximum score of 21. After SCI, the animals
were evaluated for hind limb motor function either
alone for 4 min or in pairs for 5 min every day for 3 days,
then on day 5 and weekly from 1 – 9 weeks by two
blinded observers. BBB scores (0 – 21 points) categorize
combinations of rat hindlimb movement, trunk position
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clearance and tail position, representing sequential re-
covery stages of the rat’s hind limb motor function after
SCI. A score of 0 indicates a paralyzed rat. A score of 21
indicates normal locomotion. Scores from 0 to 8 focus
on limb movement of three joints (hip, knee and ankle),
representing the early phase of recovery. Scores from 9
to 14 describe the intermediate recovery phase with re-
turn of standing and paw placement, stepping with vary-
ing degrees of forelimb-hindlimb coordination. Scores
from 14 to 20 indicate the rate with return of toe clea-
rance during the step phase, predominant paw position,
trunk stability and tail position, reflecting the late and
final phase of recovery. Two examiners were positioned
across from each other to observe both sides of the rat.
Inclined plane test
The inclined plane test measures the animal’s ability to
maintain its body position on an inclined board. Each
rat was placed on an inclined plane covered by a rubber
mat (with 0.6 mm deep grooves) constructed as reported
[58,59]. The plane can be adjusted to different slopes to
measure the animal’s ability to maintain its body po-
sition for 5 sec without falling. The animal was placed
on an inclined plane with the head to the right and the
left. The average score of the two positions was used.
The angle of the board was increased from 0° until it
reached an angle at which the rat could maintain its pos-
ition only for 5 seconds. Final readings to the nearest 5°
were taken for stationary positions. All animals were
assessed every week for 9 weeks after SCI.
The beam walk test
The beam walk was performed as described [60] using
seven wooden beams of different widths (1.7, 2.7, 3.7, 4.7,
5.7, 6.7 and 7.7 cm). Before surgery, the rats were trained
for 5 days on the plank from the widest to the narrowest
for several times each day, so that all of the rats could walk
across the 1.7 cm plank. The beam walk performance test
was conducted once a week for 9 weeks post-SCI. The ani-
mals were allowed to walk on the planks and the narrowest
plank on which they could walk without foot slip in two
trials was recorded. Rats that could walk only on the widest
plank (7.7 cm) were scored 1, and those who could walk
on the narrowest plank (1.7 cm) were scored 7.
Statistical analysis
To obtain the temporal and spatial profiles of cell loss,
the counts at each distance were compared with those
obtained in the sections at the same distance in the
sham control group over time and the counts at each
time were also compared over distance by using one-
way repeated measures analysis of variance (RMA-
NOVA) followed by the post-hoc Tukey test. Two-wayRMANOVA followed by all pairwise multiple compari-
son using the Bonferroni correction were used to evalu-
ate the spatial protection against different types of cell
loss by MnTBAP + L-NA and by MnTBAP alone against
apoptosis, and to assess the effect of MnTBAP treatment
on the hind limb motor function after SCI by behavioral
tests. This statistical procedure was also used to com-
pare DNA fragmentation between the SCI and sham
groups at different distances from the epicenter obtained
by ELISA. Caspase-3 activation in sham controls and by
distance from the epicenter was analyzed by analysis of
variance (ANOVA) followed by Dunnett’s test. The pro-
tection of MnTBAP + L-NA against apoptotic cell death
in injured and treated groups was compared by the un-
paired t-test. P < 0.05 was considered a statistically sig-
nificant difference.
Results
The quantitative temporal and spatial profiles of
motoneuron and glia loss after SCI
To obtain quantitative temporal and spatial profiles of
motoneuron and glia cell loss, the spinal cord in injured
animals were removed at 1, 6, 12, 24, 48, 72 h and 1 week
post-SCI (50 g.cm). The cords in sham-operated controls
were removed at 12 h post-laminectomy and served as
the control for all time points. The sham control animals
underwent the same surgical procedures without weight
drop injury. The spinal cords were processed for CV-
staining. After staining, the number of cells in the CV-
stained sections was counted over time from 1 h to
1 week post-SCI and over distance from 0 to 4 mm cau-
dal from the injury epicenter at 0.5 mm intervals as de-
scribed in the Methods. The counts were then compared
between sham controls and the post-SCI groups for all
time points at each distance and by distance at each time
point using one way RMANOVA followed by the post-
hoc Tukey test.
Figure 1 illustrates photomicrographs of CV-stained sec-
tions at different times post-SCI (upper panel) and at dif-
ferent distances from the epicenter (lower panel). The
sham-operated section (A, D) had many cells, including
large motoneurons in the ventral gray matter which
showed bright nuclei with nucleoli and enrichment in the
Nissl bodies. In the upper panel, at 1 h post-SCI, many
cells had been lost in the gray matter (B, E) and some neu-
rons lost their normal morphological features. At 24 h
post-SCI (C, F), almost no neurons could be observed in
the ventral gray matter. In the lower panel, at the epicen-
ter (0 mm), few cells and almost no neurons were ob-
served (B, E). At 2 mm from the epicenter (C, F), some
surviving cells including neurons were observed in the
ventral gray matter.
Figure 2 shows the temporal and spatial profiles of cell
loss. Figure 2A shows the motoneuron loss in the ventral
Sham                             1h                            24h





Figure 1 Photomicrographs of CV-stained spinal cord sections at different times post-SCI and different distances from the epicenter.
Following a laminectomy, the rat spinal cords were injured (50 g.cm), the injured cords were removed at different times post-SCI and processed
for CV staining. The upper panel shows surviving cells in CV-stained sections at 1 mm caudal from the epicenter removed at 1 and 24 h post-SCI.
The lower panel shows surviving cells in CV-stained sections at 0 and 2 mm caudal from the epicenter removed at 24 h post-SCI. A-C: Lower
magnification, D-F: higher magnification of A-C. Scale bar: A-C, 100 μm, D-F, 50 μm.
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diameter in the CV-stained sections were counted as
motoneurons. The average counts presented as mean ±
standard deviation (SD) of motoneurons at each time
and each distance from the epicenter are presented in
Table 1. The counts were compared between sham con-
trol sections and all post-SCI sections over time at 1, 6,
12, 24, 48 and 72 h, and at 1 week post-SCI for each dis-
tance (n = 3 for all). The count at each time point was
also compared to that in the sham controls at the same
distance. We found significant differences over time at
all distances examined (p = 0.02 - <0.001). Motoneurons
were significantly fewer at 0 to 1.5 mm from 1 h to 1 week
(p = 0.003 - < 0.001); at 2 mm from 12 h to 1 week (p =
0.002 - 0.01); and at 2.5 - 4.0 mm from 48 h to 1 week
post-SCI (p = 0.002 - 0.046). Comparisons by distance
(0 - 4 mm) from the epicenter at each time point re-
vealed no significant differences in the sham control
(p = 0.9) or in the post-SCI groups at 1 h (p = 0.7),
48 h (p = 0.2), 72 h (p = 0.1) and 1 week (p = 0.9).
The absence of significant differences over distance
and the small number of surviving motoneurons attimes from 48 h to 1 week show that most motoneurons
had been lost by 48 h to at least 4.0 mm from the epi-
center. Significant differences were found at 6, 12 and
24 h (p = 0.03 - <0.001) post-SCI. At 6 h, the difference
was significant over distance (p = 0.03), but no difference
was found among sections; at 12 h, the difference was
significant over distance (p < 0.001) with significantly
more motoneurons at 3 mm than at 0 and 0.5 mm (p =
0.03 for both), at 3.5 mm than at 0.5 - 1 mm (p = 0.01 -
0.04) and at 4 mm than at 0–1.5 mm (p = 0.001- 0.03);
at 24 h post-SCI, a significant different was found only
between 4 mm and 0–1 mm. By 48 h to 1 week, no sig-
nificant differences were found over distance (p = 0.1 -
0.9), indicating that most motoneurons had already been
lost at all distance examined.
Figure 2B shows the temporal and spatial profile of
glial cell loss in the ventral white matter following SCI.
Glial cells in the ventral white matter of CV-stained sec-
tions were counted as described in the Methods. The
average counts (mean ± SD) at each time and each dis-
tance from the epicenter are presented in Table 2. Signifi-
cant glial cell loss appeared at 24–72 h post-SCI in 0 mm
Figure 2 The temporal and spatial profiles of cell death after SCI. Cells in the CV-stained sections caudal from the epicenter as shown in
Figure 1 in injured or sham control sections were counted as described in the Methods and counts were then statistically compared over time
and by distance from the epicenter. The counts were presented as mean ± SD. A: The temporal and spatial profile of motoneuron loss in the
ventral gray matter of the cord after SCI. The number of surviving motoneurons increased with the distance from the epicenter at each time
point, and decreased over time at each distance after SCI. All significant differences were indicated under the dotted lines. B: The temporal and
spatial profiles of glial cell loss in the ventromedial white matter following SCI. Significant glial loss in the white matter was found only near the
epicenter; such loss was not significant at 2 mm from the epicenter at any time post-SCI. * indicates significant difference between sham control
and SCI (p < 0.05).
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0.5 - 1.5 mm sections compared to sections from sham-
operated controls (p = 0.047 - 0.003). At 72 h post-SCI,
glial cells began proliferating and significantly more glial
cells were found at 72 h than at 24 and 48 h post-SCI,
but only in 1.5 mm sections (p = 0.02-0.03). By 1 week, the
number of glial cells at 0.5 mm was significantly higher
than at 24 and 48 h (p = 0.006 - 0.03); higher at 1 mm
than at 6–48 h; and higher at 1.5 mm than at 24 and
48 h (p = 0.047 - <0.001) post-SCI. Glial loss in the ventral
white matter was much slighter than motoneuron loss inthe ventral gray matter, and the loss was quickly offset by
proliferation (n = 3 for all time points and all distances).
Morphological characterization of SCI-induced neuronal
and glial apoptosis
By counting TUNEL-positive cells in the sections 0, 1, 2
and 4 mm from the epicenter in the cord removed at
1 h to 1 week post-SCI, we found that the number of
TUNEL-positive cells in the ventral gray matter peaked at
12 to 48 h post-SCI and maximized at the distances of 1
and 2 mm from the epicenter [43]. Therefore, in this
Table 1 The average number of motoneurons in the ventral gray matter of rat spinal cords
Time post-SCI (h) Distances caudal from the epicenter (mm)
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
Sham 9.3 ± 1.0 10.2 ± 1.3 9.4 ± 0.3 9.8 ± 0.8 9.8 ± .8 8.4 ± 1.5 8.9 ± 1.0 9.2 ± 0.7 8.6 ± 0.3
1 2.6 ± 2.2 3.1 ± 2.0 3.3 ± 0.3 3.1 ± 2.1 3.7 ± 2.0 3.9 ± 1.3 5.4 ± 1.3 4.3 ± 1.3 4.9 ± 0.4
6 0.8 ± 1.3 0.4 ± 0.7 1.4 ± 1.3 2.3 ± 2.0 4.0 ± 1.2 4.7 ± 0.8 5.2 ± 1.6 5.6 ± 2.1 6.1 ± 3.5
12 0.2 ± 0.2 0.1 ± 0.3 0.8 ± 1.2 1.7 ± 1.2 2.5 ± 2.7 3.7 ± 2.8 4.9 ± 2.8 5.4 ± 2.4 6.6 ± 1.6
24 0 0 0 1.04 ± 1.9 1.9 ± 2.5 3.2 ± 2.5 4.3 ± 2.2 4.8 ± 2.6 5.4 ± 1.0
48 0.3 ± 0.3 0.2 ± 0.3 0.1 ± 0.1 0.22 ± 0.3 1.4 ± 1.2 1.5 ± 1.2 0.8 ± 0.6 1.7 ± 1.1 1.9 ± 0.8
72 0 0 0.2 ± 0.4 0.1 ± 0.1 0 0.7 ± 0.9 0.8 ± 1.1 1.4 ± 0.3 1.4 ± 1.1
168 0 0 0 1.6 ± 2.7 0.8 ± 1.3 0.9 ± 3.1 2.5 ± 3.7 0.8 ± 0.6 2.1 ± 0.8
The number of motoneurons at different times post-SCI and different distances from the epicenter was presented as mean ± SD (n = 3 for all).
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ized morphologically as described in the Methods at 12 or
24 h post-SCI and at 2 mm rostral from the epicenter by
the following staining: 1) TUNEL and immunohistochem-
ical double staining with antibodies against specific cell
markers of different types of cells (anti-NSE for neurons,
anti-ChAT for motoneurons and anti-GFAP for astro-
cytes); 2) TUNEL and anti-ChAT immuno-histochemical
and immuno-fluorescence double staining of apoptotic
motoneurons; and 3) active caspase-3 and specific cell
marker double immuno-fluorescence staining of apoptotic
neurons and astrocytes. Neuronal and glial apoptosis was
confirmed by transmission electron microscopy.
Figure 3 illustrates the photomicrographs of the mor-
phological characterization of apoptosis in neurons and
astrocytes. DNA fragmentation is an event of apoptosis
and TUNEL stains the fragmented DNA in the nuclei.
Anti-NSE and anti-GFAP immunohistochemical staining
identifies neurons and reactive astrocytes, respectively. A
to D in Figure 3 show the photomicrographs of TUNEL
and NSE or GFAP immunohistochemically double-stained
sections in the ventral horn of the gray matter in an injured
spinal cord sections 2 mm rostral from the epicenter re-
moved at 24 h post-SCI. The arrowheads in B indicateTable 2 The average number of glial cells in the ventral white
Time post-SCI (h) Distances ca
0.0 0.5 1.0 1.5
Sham 41.4 ± 0.7 41.3 ± 1.8 41.6 ± 2.5 40.0 ± 1.3
1 35.7 ± 4.9 34.2 ± 0.4 34.8 ± 3.1 37.2 ± 1.2
6 28.9 ± 4.0 32.0 ± 3.8 30.1 ± 8.3 33.8 ± 4.2
12 26.1 ± 8.1 27.0 ± 5.4 28.3 ± 6.7 33.5 ± 4.0
24 13.7 ± 6.6 18.4 ± 1.1 23.0 ± 3.9 22.2 ± 4.2
48 10.9 ± 5.3 12.7 ± 6.1 17.2 ± 8.0 21.8 ± 9.7
72 14.0 ± 1.5 28.3 ± 11.5 32.1 ± 9.0 38.1 ± 6.2
168 28.7 ± 21 42.8 ± 17.3 47.6 ± 3.4 41.7 ± 5.4
The number of glial cells at different times post-SCI and different distances from thTUNEL-positive nuclei in NSE-positive neurons. The
arrows in D indicate TUNEL-positive nuclei in GFAP-
positive astrocytes. These double-stained spinal cord
sections localize the apoptotic DNA fragmentation in the
nuclei of neurons (A and B) and astrocytes (C and D). This
is the morphological indication of neuronal and glial apop-
tosis. Since caspase-3 activation occurs prior to DNA frag-
mentation, the injured spinal cord was removed at 12 h
post-SCI in this study for active caspase-3 staining. E to J in
Figure 3 show the photomicrographs of active caspase-3
and NSE or GFAP immuno-fluorescence double-stained
apoptotic astrocytes (E - G) and neurons (H - J), respec-
tively, in the spinal cord sections 2.05 mm rostral from the
epicenter removed at 12 h post-SCI. E to G show double
immuno-fluorescence-stained sections with antibodies
against an active fragment p20 of caspase-3 and anti-
GFAP. E shows astrocytes (GFAP-positive, arrows) and F
shows the same astrocytes stained for p20 (arrows). G
is the colocalization of E and F, showing caspase-3-
positive astrocytes (arrows). H to J show double immuno-
fluorescence-stained neurons. H shows NSE-positive neu-
rons (arrow head). I shows that the same neurons are also
p20-positive (arrow head). J is colocalization of H and I,
showing active caspase-3-positive neurons (arrow head).matter of rat spinal cords
udal from the epicenter (mm)
2.0 2.5 3.0 3.5 4.0
40.5 ± 0.9 42.3 ± 1.5 41.1 ± 2.7 39.3 ± 2.4 40.0 ± 3.1
33.2 ± 0.7 37.9 ± 0.4 39.4 ± 0.4 39.3 ± 0.5 39.2 ± 1.6
33.5 ± 2.2 34.6 ± 3.2 36.7 ± 0.7 34.8 ± 2.4 35.6 ± 0.3
37.2 ± 4.9 34.1 ± 3.1 34.2 ± 3.3 35.7 ± 2.8 35.7 ± 0.3
34.1 ± 5.5 36.8 ± 4.8 35.1 ± 2.2 35.7 ± 4.0 36.2 ± 0.3
36.8 ± 3.4 34.4 ± 5.3 38.1 ± 0.8 32.3 ± 0.7 38.5 ± 0.8
34.8 ± 4.5 39.3 ± 4.3 41.7 ± 2.07 37.3 ± 0.7 40.3 ± 4.4
42.2 ± 7.0 39.4 ± 4.3 40.2 ± 2.8 34 ± 8.1 34 ± 7.2
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Figure 3 Photomicrographs of the morphological
characterization of apoptotic neurons and astrocytes. A-D:
photomicrographs of TUNEL and immunohistochemical double-stained
sections 2 mm rostral from the epicenter in the ventral horn of
injured spinal cords removed at 24 h post-SCI. A and B: TUNEL and
NSE double-stained TUNEL-positive neurons at lower (A) and higher
(B) magnifications. The arrowheads indicate TUNEL-positive nuclei in
NSE-positive neurons. C and D: TUNEL and GFAP double-stained
TUNEL-positive astrocyte at lower (C) and higher (D) magnifications.
The arrows indicate TUNEL-positive nuclei in GFAP-positive astrocytes.
E-J: photomicrographs of active caspase-3 and immuno-fluorescence
double-stained sections 2.05 mm rostral from the epicenter in the
ventral gray matter of injured spinal cords removed at 12 h post-SCI.
E-G: p20 fragment and GFAP double-stained active caspase-3 with
active astrocytes. E: active astrocytes (GFAP-positive, arrows); F: the
same astrocytes stained for p20 (arrows). G: immuno-colocalization of
E and F, showing caspase-3-positive astrocytes (arrows, yellow). H-J:
p20 fragment and NSE double-stained neurons. H: NSE-positive
neurons (arrowhead); I: the same neurons were also p20-positive
(arrowhead). J: immuno-colocalization of H and I showing caspase-
3-positive neurons (arrowhead, yellow). Scale bar = 100 μm.
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caspase-3 activation in the neurons and astrocytes and
provided another morphological indication of neuronal
and glial apoptosis.
In the spinal cord, most ChAT immuno-reactive neu-
rons are motoneurons. Using ChAT and TUNEL double-
staining, we found that a number of ChAT-positive neu-
rons were also TUNEL-positive in the ventral horn of
spinal cord sections 2 mm rostral from the epicenter re-
moved at 24 h post-SCI, indicating motoneuron apoptosis
(Figure 4A-C). Motoneuron apoptosis was further shown
by the ChAT and TUNEL double immuno-fluorescence
colocalization (Figure 4D-F). ChAT-immuno-staining
showed red cell bodies of motoneurons (D) and TUNELChAT + TUNEL ChAT + TUNEL
Figure 4 Photomicrographs of the morphological characterization
of apoptotic motoneurons. A-C: Photomicrographs of TUNEL and
ChAT double immunohistochemical stained section at 2 mm rostral
from the epicenter removed at 24 h post-SCI. A: lower magnification
of the ventral gray matter; B: higher magnification corresponding to the
frame in A; C: high magnification corresponding to the frame in B. Two
enlarged TUNEL-positive motoneurons were shown in the frames of C.
Scale bar, 100 μm. D-F: Photomicrographs of TUNEL and ChAT double
immuno-fluorescence stained section at 2.05 mm rostral to the epicenter
removed at 24 h post-SCI. The section was double immuno-stained with
anti-ChAT primary antibody (D, red) and TUNEL (E, blue), followed by
anti-mouse Alexa Fluor 594 secondary antibody. F: immuno-colocalization
of D and E showing apoptotic motoneurons (bluish red) in the ventral
gray matter of the cord from a vehicle control rat. Photomicrographs are
taken at high magnification (scale 100 μm).
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gray matter of the cord from a section 2.05 mm rostral
from the epicenter removed at 24 h post-SCI. The blue
TUNEL-stained nuclei were localized clearly in the red
ChAT-positive cell bodies of motoneurons (F. arrows).
SCI-induced apoptosis was confirmed by TEM identi-
fication based on the specific morphology of apoptosis.
Figure 5 illustrates the ultra-fine structural changes in
apoptotic cells in layer VIII of the ventral horn in the gray
matter of the spinal cord sections at 2-2.5 mm rostral
from the epicenter removed at 24 h post-SCI (50 g.cm).


















Figure 5 TEM confirmation of neuronal and glial apoptosis. The tissue
horn of the cord and the 2–2.5 mm rostral from the epicenter were proces
sham control (×14,300). B: a degenerating neuronal axon (×3,300). C (×24,4
neurons and glial cells. Symbols: N-Nucleus, M-Mitochondria, R- Rough endepicenter, shows a normal neuron with a large, euchro-
matic (pale-staining) nucleus (N), abundant rough endo-
plasmic reticulum (R), mitochondria (M), and Golgi
complexes (G) in the cytoplasm. Figure 5B-F show differ-
ent stages of apoptosis and degeneration from injured ani-
mals. B shows a degenerating swollen axon (arrow) with
vacuoles. C-F shows very early to late stages of apoptotic
degeneration of neuronal and glial cells. C shows a
very early stage apoptotic neuron with condensed
chromatin (Ch) in the rim of the nucleus (arrow) and
unchanged organelle in the cytoplasm. D shows a nor-
mal glial cell (arrow) with a smaller cell body andN
for TEM was obtained at 24 h post-SCI from layer VIII of the ventral
sed for TEM as described in the Methods. A: a normal neuron from
75); D (×14,300); E (×42,625); F (×18,150): different stages of apoptotic
oplasmic reticulum, G-Golgi complex, Ch-Chromatin.
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the nucleus of the neuron. An apoptotic glial cell near
the normal glial cell (arrow head) is shrinking, becom-
ing denser and the chromatin undergoing condensa-
tion to form an irregular dense mass while the
organelles are becoming indiscernible. E shows the
early stage of an apoptotic neuron with condensed
chromatin accumulated mainly at the nuclear rim; the
organelles are intact. F represents a nucleus which is
fragmented and has formed highly condensed apop-
totic bodies (arrow head). A phagocyte (arrow) is
shown engulfing the apoptotic body.
Biochemical characterization of apoptosis in spinal cord
tissues following SCI
Apoptotic DNA fragmentation was characterized by spe-
cific laddering of radiolabeled DNA fragments and quanti-
tated by ELISA. Activation of caspase-3 was also analyzed
biochemically. As described in the Methods, after impact
injury to the rat spinal cords, the cords were frozen in situ
and cut into three sections of equal length (1 cm) with
section 1 centered at the injury epicenter and sections 2
and 3 adjacent and caudal to section 1. Since the number
of TUNEL-positive cells peaked at 12 – 48 h post-SCIA









Figure 6 Biochemical evidence of apoptosis. The spinal cord was remo
divided into three sections of equal length (1 cm each) with section 1 cen
caudal to the epicenter for DNA laddering and ELISA as described in the M
Lane 1, standard DNA marker; lane 2, the tissue obtained from the epicent
respectively; and lane 5, tissue from a sham-operated rat. The fragmented D
sections of one rat (60 mg wet weight tissue). The results are representativ
DNA by ELISA with 3 sections at epicenter, 1 and 2 cm caudal from the ep
Error bars: mean ± SEM. Both A and B show significantly decreased DNA fra
Caspase-3 activation analyzed at 4 h post-SCI. The injured cord was divided
section 2 centered 1 cm from the epicenter. Error bars: mean ± SEM. The c
epicenter compared to 1 cm from the epicenter and sham control.[43], in this study, DNA fragmentation was characterized
at 48 h post-SCI or post-laminectomy for sham controls.
Since apoptosis appeared as early as 4–6 h post-SCI [4,43]
and caspase activation occurs prior to apoptotic DNA frag-
mentation, caspase-3 activity was analyzed at 4 h post-SCI.
Figure 6 represents the results of our biochemical ana-
lysis. Figure 6A shows autoradiographs of DNA fragments
analyzed by agarose gel electrophoresis from the cords ex-
tracted at 48 h post-SCI (lanes 2 – 4) and the sham-
operated control (lane 5). Fragmented DNA displayed a
ladder-like electrophoretic pattern. The intensity of the
ladder was higher in lane 2 (epicenter) than in lane 3 (sec-
tion 2 – 1 cm from the epicenter). No fragmented DNA
bands were observed in lane 4 (section 3 – 2 cm from the
epicenter). The sham-operated sample (lane 5) did not
show any detectable fragmentation. DNA fragmentation
was quantitated by ELISA (Figure 6B). The cellular DNA
isolated from three sections of injured spinal cord tissue
showed a significantly higher absorbance at 405 nm than
did the three corresponding sections in the sham-
operated rats (n = 6, p < 0.001, RMANOVA followed by all
pairwise multiple comparison with the Bonferroni correc-
tion). The average increases in the three injured sections
were 2- to 10-fold that of corresponding sham controls.0 1              2 










From the epicenter (cm)
1 0
*
ved at 48 h post-SCI by being frozen in situ with liquid nitrogen and
tered at the epicenter and sections 2 and 3 centered at 1 and 2 cm
ethods. A: The laddering of DNA fragments in the spinal cord tissue.
er; lanes 3 and 4, tissue centered 1 and 2 cm away from the epicenter,
NA shown in each lane was obtained from the corresponding
e of four separate experiments. B: Quantitative analysis of fragmented
icenter. Each sample for ELISA analysis equaled 2 mg wet weight tissue.
gmentation with an increase in distance from the epicenter. C:
into two sections with section 1 centered at the injury epicenter and
aspase-3-like protease activity was significantly higher at the injury
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http://www.biomedcentral.com/1471-2202/14/146Fragmented DNA in the injured tissue was more abun-
dant in the epicenter (section 1) than in 1 (section 2) and
2 (section 3) cm from the epicenter (p < 0.001), and in
1 cm than in 2 cm caudal from the epicenter (p = 0.01).
The decline over distance from the injury site measured
by ELISA (Figure 6B) was comparable to the decline
in intensity of DNA laddering over the same distance
(Figure 6A). Figure 6C shows caspase-3 activation at 4 h
post-SCI. The caspase-3-like protease activity was mea-










































Figure 7 Reduction of SCI-induced cell loss by MnTBAP + L-NA. MnTB
6 h post-SCI (50 g.cm) and the rats were sacrificed at 12 h post-SCI. Upper
spinal cord sections at 2 mm rostral from the epicenter. A-C: lower magnif
MnTBAP and L-NA treatment increased the number of surviving cells in the
μm, respectively. Lower panel: spatial protection by MnTBAP + L-NA agains
and motoneurons (c). * indicates a significant difference between the com
mean ± SEM. Compared to vehicle-treated rats, the combination significanprotease activity was significantly higher in the epicenter
(section 1) of the cords than at 1 cm from the epicenter
(section 2) in the injured cords (n = 5) or in the sham con-
trol (n = 4, p = 0.03 for both). Results for the sham control
and 1 cm from the epicenter did not differ significantly.
MnTBAP + L-NA treatment reduced secondary cell loss
and the number of TUNEL-positive cells after SCI
For the reason mentioned in the Background, a combin-
ation of MnTBAP (10 mg/kg) plus L-NA (1 mg/kg) wasC
F
I              MnTBAP + L-NA
om epicenter (mm)
AP (10 mg/kg) plus L-NA (1 mg/kg) was given i.p. at 15 min pre- and
panel: photomicrographs of the ventral gray matter in the CV-stained
ication, D-F: higher magnification of A-C. Clearly, the combination of
gray matter of the cord. Scale bars shown in C and F: 100 and 50
t losses of total cells in gray matter (a), glial cells in white matter (b),
bination-treated and the vehicle-treated groups (p < 0.05). Error bars,
tly reduced cell loss in both the gray and the white matter.


































Figure 8 MnTBAP + L-NA reduced SCI-induced apoptosis. Spinal
cord sections were obtained at 12 h post SCI as in Figure 7. Upper:
photomicrographs of TUNEL-stained sections at 2 mm rostral from
the epicenter in the gray matter of the cord. A-C: lower magnification
and D-F: higher magnification of A-C. A and D: sham control;
B and E: injured section; C and F: injured section treated with
MnTBAP + L-NA. Treatment by MnTBAP + L-NA clearly reduced the
number of TUNEL-positive cells. The TUNEL-positive cells at the
sections 2 mm from the epicenter were counted in both the gray
and the white matter and the counts compared between the
combination-treated and vehicle-treated groups (lower panel). a:
Number of TUNEL-positive cells in the gray matter. b: Number of
TUNEL-positive cells in the white matter. Error bars, mean ± SEM. Asterisk
indicates a significant difference between the two treatment groups
(p < 0.05). The combination of MnTBAP + L-NA significantly reduced the
number of TUNEL-positive cells in both the gray and the white matter.
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combination was given (i.p) at 15 min pre- and 6 h post-
SCI (50 g.cm), then the cord was removed at 12 h post-SCI
for CV-staining. The total surviving cells and motoneurons
(neurons larger than 25 μm in diameter) were counted in
the gray matter, and the surviving glial cells were counted
in the white matter in the CV-stained sections 0 – 4 mm
rostral from the epicenter at 0.5 mm intervals. The
upper panel of Figure 7 provides photomicrographs of
CV-stained sections showing that MnTBAP+ L-NA treat-
ment reduced cell loss in sections 2 mm rostral from
the epicenter in the ventral gray matter of the cord at
12 h post-SCI. Many motoneurons were observed in the
ventral gray matter of the cord in the sham control sec-
tions (A, D). Dramatic motoneuron loss was observed in
the vehicle-treated group (B, E). The motoneuron loss was
attenuated by the MnTBAP + L-NA treatment (C, F), sug-
gesting that RS contribute to motoneuron loss in SCI. The
number of cells in sections at different distances from the
epicenter were compared between the combination-
treated (n = 6) and the vehicle-treated (n = 5) groups using
two-way RMANOVA followed by pairwise multiple com-
parisons with the Bonferroni correction. We found that
the combination treatment significantly reduced: total cell
loss in the gray matter of sections 1.5 – 2.5 mm rostral
from the epicenter (p = 0.02 - < 0.001, Figure 7a); glial cell
loss in the ventromedial white matter of sections 0 -
1.0 mm rostral from the epicenter (p = 0.01 - 0.002,
Figure 7b); and motoneuron loss at 2.0 and 2.5 mm from
the epicenter (p < 0.05 and p = 0.01, Figure 7c) compared to
vehicle-treated rats (lower panel, Figure 7).
Since the number of TUNEL-positive cells in the gray
matter peaked from 12 to 48 h post-SCI [43], the effect
of MnTBAP + L-NA on apoptosis was evaluated at 12 h
post-SCI by counting the TUNEL-positive cells in the
gray and white matter in the vehicle- and combination-
treated sections as described above (Figure 8). The
upper panel of Figure 8 provides photomicrographs of
TUNEL-stained sections 2 mm rostral from the epicen-
ter in the gray matter of the cord at 12 h post-SCI. The
sham control sections showed no TUNEL-positive cells
in the gray matter of the cord (A, D). In the SCI group
(B, E), many TUNEL-positive cells appeared. Treatment
with the combination clearly reduced the number of
TUNEL-positive cells (C, F). The cells in the sections
2 mm rostral from the epicenter in the vehicle-treated
(n = 5) and the combination-treated groups (n = 6)
were counted and the counts compared using unpaired
t-test. The quantitative comparison demonstrated that
the MnTBAP + L-NA treatment significantly (p = 0.01)
reduced the number of TUNEL-positive cells in the
gray (Figure 8a) and white (Figure 8b) matter, sugges-
ting that RS contribute to apoptotic DNA fragmenta-
tion following SCI.MnTBAP alone reduced the number of TUNEL-positive
cells after SCI
To test the effect of MnTBAP treatment on cellular
apoptosis, the cords of MnTBAP-treated and vehicle-
control animals (n = 5 for both groups) were removed at
24 h post-SCI. The sections at 0–4 mm rostral from the
epicenter in the two groups of animals were stained with
TUNEL and the number of TUNEL-positive cells was
counted (Figure 9). The counts in MnTBAP-treated sec-
tions were compared with those in vehicle-treated sec-
tions by two-way RMANOVA followed by pairwise
Figure 9 MnTBAP protection against apoptotic cell loss
following SCI. MnTBAP (10 mg/kg, ip) was administered as in
Figures 7 and 8 and the rats were sacrificed at 24 h post-SCI. The
number of TUNEL-positive cells was counted in the gray matter in the
sections at 0 – 4 mm rostral from the epicenter at 1 mm intervals. The
counts in MnTBAP-treated sections were compared with those in
vehicle-treated sections. * indicates a significant difference between
the MnTBAP-treated and the vehicle-treated groups (P < 0.05). Error
bars, mean ± SEM. Compared to vehicle-treated rats, 10 mg/kg
MnTBAP significantly reduced the number of TUNEL-positive cells.
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We found that 10 mg/kg MnTBAP given i.p. signifi-
cantly (p = 0.01) reduced the number of TUNEL-positive
cells over distance compared with the vehicle-treated
group. Comparisons by treatment (saline vs. MnTBAP)
using pairwise multiple comparisons indicated a signifi-
cant difference (p < 0.001). Comparisons by distance
within the saline group indicated that significantly more
TUNEL-positive cells appeared at the distances of 0, 1
and 2 mm than at 4 mm from the epicenter (p < 0.001
for all) with no significant difference in number at
shorter distances from the epicenter, indicating that
injury-induced apoptosis extended from the epicenter to
less than 4 mm away. Comparisons by distance within
the MnTBAP treatment group indicated that signifi-
cantly more TUNEL-positive cells appeared at 1 mm
only than at 4 mm from the epicenter (p < 0.001), sug-
gesting the protective effect of MnTBAP. Comparisons
of the number of TUNEL-positive cells between saline-
and MnTBAP-treated sections at each distance rostral
from the epicenter demonstrated that MnTBAP signifi-
cantly reduced the number of TUNEL-positive cells at 0, 1,
and 2 mm (p < 0.001, for all), but not at 4 mm, from the
epicenter with the counts of 31 ± 12, 45 ± 5, 32 ± 5 and 3 ±
2 at 0, 1, 2 and 4 mm, respectively, rostral from the epicen-
ter in the vehicle-treated group reduced to 11 ± 0.6, 23 ±
3.2, 13 ± 1.6 and 2 ± 0.6 (mean ± SEM) in the correspon-
ding sections in the MnTBAP-treated group. In other
words, the counts of TUNEL-positive cells in vehicle-
treated sections were approximately 3, 2 and 2.5 times
higher at 0, 1 and 2 mm from the epicenter than those in
the corresponding sections of the MnTBAP-treated groups.This again indicates that RS contribute to apoptotic DNA
fragmentation following SCI.
MnTBAP improved functional recovery after SCI
SCI-induced neurological deficits and the ability of
MnTBAP alone to protect against such dysfunction were
evaluated by the BBB test, beam walk test and the in-
clined plane test for 9 weeks. Behavioral test scores were
compared by two-way RMANOVA followed by pairwise
multiple comparisons between MnTBAP (n = 8) and
sham (n = 4), saline (n = 7) and sham, and MnTBAP and
saline groups. Eight rats were used for behavioral tests
in the injured groups. However, due to the loss of body
weight, one rat in the vehicle-treated group was termi-
nated. Therefore the data obtained in this group were
from 7 rats.
MnTBAP significantly improved the BBB scores
The rats were evaluated for hind limb motor function
pre-SCI and at 1, 2, 3 and 5 days and 1–9 weeks post-
SCI (Figure 10A) as described in the Methods. All ani-
mals started with baseline BBB scores of 21. In the in-
jured with vehicle-treated group, all animals manifested
bilateral hind limb paralysis immediately following injury
and gradually recovered. The overall scores in the sham-
operated group were significantly higher than in the
vehicle-treated group (p < 0.001) and the MnTBAP-
treated group (p = 0.01); the sham-operated group had
no significant differences in scores over time during the
9 weeks of observation and no significant difference in
scores at any time point, as expected. In the vehicle-
treated SCI group, the BBB scores: at 9 weeks were
significantly higher than at 1–5 days and 1–4 weeks
(p = 0.02 for 4 weeks and p < 0.001 for the rest); at 7 and
6 weeks were significantly higher than at 1–5 days and
1–3 weeks (p = 0.001 for 3 weeks and p < 0.001 for
the rest); at 5 weeks were significantly higher than at
1–5 days and 1–2 weeks (p = 0.006 for 2 weeks and
p < 0.001 for the rest); and at 2–4 weeks were signi-
ficantly higher than at 1–5 days and 1 week (p = 0.008
for 1 to 2 weeks and p < 0.001 for all the rest). Even at
1 week, the scores were significantly higher than at 1–3 days
(p = 0.001 for 3 days and p < 0.001 for 1 and 2 days).
Scores did not differ significantly over 1 to 5 days. The
scores gradually increased from very low during the first
5 days to higher scores by 9 weeks, indicating a gradual
recovery even without treatment. As early as the first
day post-injury, the MnTBAP-treated rats showed more
movement of their hind limbs than did vehicle-treated
animals. MnTBAP treatment significantly increased the
overall BBB scores compared with the vehicle-treated
group over time (p < 0.001) with significantly greater
scores at days 1 to 5 (p = 0.003 - 0.01) and at weeks 1





































































Figure 10 MnTBAP protection against functional deficits
following SCI. The spinal cords of rats were injured at vertebra T10
(12.5 g.cm) using the NYU device. The behavioral tests were
performed on animals treated with MnTBAP and saline, and on
sham control animals as described in the Methods. MnTBAP (10 mg/kg)
or saline was given by i.p. injection at 15 min pre- and 4 h post-SCI for
behavioral tests. All experiments were triple blinded. A: results of the
BBB test. B: results of the beam walk test. C: results of the inclined plane
test. Clearly, MnTBAP treatment significantly improved the functional
recovery following SCI relative to the vehicle-treated animals in all three
tests. Error bars: mean ± SEM. * indicates a significant difference between
the groups of injured with vehicle-treated and the sham controls.
# indicates a significant difference in the injured groups between
vehicle-treated and MnTBAP-treated.
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group were consistently better than those in vehicle-
treated animals.
MnTBAP significantly increased the beam walk scores
The beam walk performance was tested weekly at 1 to
9 weeks post-SCI (Figure 10B) as described in the
Methods. The rats were pre-trained for 5 days so that all
of them could walk through the narrowest beam
(1.7 cm). The 4 sham-operated rats retained this ability
during the entire study. SCI significantly (p < 0.001) de-
creased the score of the beam walk test in injured ani-
mals compared with the sham-operated controls,
dropping immediately after injury and continuing at all
time points (p < 0.001 for all). MnTBAP treatment sig-
nificantly increased the overall scores (p = 0.02) reduced
by SCI within 9 weeks post-SCI with significant in-
creases at weeks 2 to 6 (p = 0.04 – p = 0.005), but not at
weeks 1 (p = 0.07) and 7 (p = 0.09).
MnTBAP significantly increased the angles of inclined plane
This test was performed weekly at 1 to 9 weeks post-SCI
(Figure 10C). In the sham-operated control group, all
animals remained at the maximum angle to stay on the
inclined plane at all times. Injury significantly (p < 0.001)
reduced the maximum angle from week 1 to 7 compared
with sham controls (p = 0.03 - <0.001). MnTBAP treatment
significantly increased the angles over time compared to
the vehicle-treated groups (p = 0.01), but not in comparison
to the sham groups (p = 0.10). MnTBAP treatment signi-
ficantly increased the angle of the inclined plane at weeks
1–2 and week 7 post-SCI (p = 0.04 - p < 0.001) relative to
vehicle-treated animals.
Discussion
Using a weight drop SCI model, the present study estab-
lished the temporal and spatial profiles of motoneuron
and glial cell loss after SCI, demonstrated that apoptosis
is the common mechanism for different types of cell
death after SCI, and characterized and quantitated apop-
tosis at different distances from the injury epicenter. The
ability of the catalytic antioxidant MnTBAP and of the
combination MnTBAP + L-NA to protect against SCI-
induced cell loss and apoptosis were explored. The ef-
fectiveness of MnTBAP alone to attenuate neurological
dysfunction was also evaluated.
Comparing our temporal and spatial profile of moto-
neuron loss following SCI in the present study (Figure 2A)
with the profile of total neuron loss that we reported previ-
ously [43], we found that motoneuron loss had the same
pattern as neuron loss: increase over time and decrease
over distance from the epicenter. However, the significant
loss of motoneurons occurred earlier and spread away
from the epicenter quicker than total neuron loss. From
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significantly differ by distance, indicating that most moto-
neuron loss occurred within this period. Although moto-
neurons are located in the ventral gray matter, farther from
the impact site than total neurons, motoneuron loss was
more severe than total neuron loss (Figure 2A). Our quan-
titative profile of motoneuron loss extended the informa-
tion reported hitherto [61] from 24 h to one week.
Compared with the neuron and motoneuron loss in the
ventral gray matter, our temporal and spatial profile of
glial loss in the ventral white matter (Figure 2B) showed a
different pattern: a delayed (starting at 24 h post-SCI),
much diminished and more concentrated at the epicenter
(at 0 - 1.5 mm from the epicenter) and quickly decreased
(by 72 h post-SCI) due to proliferation. One report [61]
found significant glia loss in the ventromedial white matter
at 15 min after thoracic SCI. Our observation of significant
glial loss starting at 24 h post-SCI may be attributed to
the differences in the impact site, as Bresnahan et al. [62]
indicated that a similar impact force produces shorter,
more truncated lesion sites at lumbar levels with less in-
volvement of the white matter than in thoracic lesions, as
determined by the three-dimensional structure of lesion
sites [62]. The injury site in most previous studies of SCI
was at vertebrae T9 [51,63] or T10 [6,13,52-54]. Our pro-
files of cell loss and apoptosis were established from cord
injured at vertebra T13, equal to lumber L2 of the cord
within the lumbar enlargement. This added new informa-
tion for a severe injury in the lumber enlargement where
the hind limb motoneurons are located. Cell loss in the
lumbar enlargement is more related to residual locomotor
function than corresponding loss at other sites [62].
Apoptosis is characterized by changes such as cell sur-
face blebbing, cell shrinking, formation of apoptotic bod-
ies, nuclear chromatin condensation, compaction of the
cytoplasmic organelles, nuclear lobation and a typical
ladder-like electrophoretic pattern of DNA cleaved into
nucleosome-size fragments of 180-200 bp or multiples
thereof [64]. DNA fragmentation can be observed morpho-
logically by TUNEL staining and quantitated biochemically
by ELISA. Numerous endogenous agents formed upon ini-
tial insult can cause apoptosis through different pathways,
many of which converge at the caspase activation cascade
[65,66]. Active caspase-3 is the downstream executioner of
the caspase cascade [67]. Caspase-3 activation follows
SCI [6,68-70]. The discovery that some apoptotic cells
do not necessarily go through DNA fragmentation and
that cells with DNA fragmentation may die by necrosis
led to the use of caspase-3 activation as another indica-
tor of apoptosis. Therefore, in addition to characterizing
DNA fragmentation by TUNEL, DNA laddering, and
ELISA, this study also detected caspase-3 activation to
further characterize apoptosis. Although apoptosis has
been reported frequently after SCI, as cited in theBackground section, few reports have qualitatively and
quantitatively studied SCI-induced apoptosis in the lum-
bar enlargement.
In our previous study, using TUNEL staining as a marker
of possible apoptosis, we obtained the temporal and spatial
profile of total TUNEL-positive cells. Using TUNEL and
NSE double staining, we also established the profile of
TUNEL-positive neurons in the lumbar enlargement area
after SCI [43]. The present study, further morphologically
characterized neuronal and glial apoptosis in the lumbar
enlargement using the sections selected at the peak time
and distance of apoptosis according to our previously
established profiles. TUNEL or active caspase-3 as apop-
tosis markers were double stained with specific cell
markers (NSE, ChAT and GFAP). The TUNEL-positive or
active caspase-3-positive neurons, motoneurons and as-
trocytes in the double-stained sections in the ventral gray
matter of injured spinal cords were observed at 24 h (for
TUNEL + cell markers) and 12 h (for active fragment p20
of caspase-3 + cell marker) post-SCI (Figures 3 and 4),
indicating apoptosis of neurons, motoneurons and as-
trocytes. Neuronal and glial apoptosis was confirmed by
TEM, a gold standard to determine apoptosis based on
its specific morphology. Figure 5 illustrates the different
stages of neuronal and glial apoptosis by observation of
their ultra-structural changes in the ventral gray matter
in spinal cord sections removed at 24 h post-SCI, as
described in the Results. Motoneuron apoptosis have
been reported following compression SCI [69,71], but few
reports are available of motoneuron apoptosis after contu-
sion SCI. Our characterization provides important evidence
for motoneuron apoptosis after contusion SCI in the lum-
bar enlargement. Using TUNEL staining for DNA fragmen-
tation and casepase-3 activation as two indicators of
cellular apoptosis, our data support the notion that apop-
tosis is a common mechanism for neurons, motoneurons
and glial cells to die following contusion SCI.
Apoptotic DNA fragmentation was also characterized
biochemically in the spinal cord tissue by DNA laddering
and quantitated by ELISA at 48 h (when the maximum
number of TUNEL-positive cells appeared) post-SCI.
Agarose gel electrophoresis and autoradiography indicated
that the intensity of DNA fragment ladders was higher in
the epicenter than 1 cm away from the epicenter, and no
fragmented DNA bands were observed at 2 cm away from
the epicenter or in the sham-operated sections. Compared
with the size markers, these DNA fragments were con-
firmed to have characteristic oligonucleosome-length frag-
ments at intervals of about 180 bp (Figure 6A). ELISA
quantitation demonstrated that DNA fragmentation
decreased with distance from the epicenter. The values in
injured animals for each section were 2- to 10-fold that
of the corresponding sections in sham-operated rats
(Figure 6B). The decline in values over the distance from
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the decline in intensity of DNA laddering over the same
distance. The fact that fragmentation was detected in tis-
sue 2 cm from the epicenter and in the sham controls by
ELISA, but no bands were observed in these samples by
electrophoresis reflects the greater sensitivity of ELISA
over DNA laddering. We also demonstrated that the
caspase-3-like protease activity was significantly higher at
the epicenter than 1 cm away from the epicenter or in the
sham control (Figure 6C). Lack of caspase-3 activity at
1 cm from the epicenter may be attributed to the early
measurement of caspase-3 activation at 4 h post-SCI.
Apoptosis is important in regulating normal development
and maintaining tissue homeostasis in the adult. However,
too much or too little apoptosis may result in pathological
disorders. Therefore, there should be a basal level of apop-
tosis in the normal cord. This basal level was measured in
the present study by ELISA in the sham-operated cord
(Figure 6B). As mentioned in the Methods, to establish
the temporal and spatial profile of cellular apoptosis, the
TUNEL-positive cells were counted from 0 to 4 mm caudal
from the epicenter at 1 h to 1 week post-SCI. At 4 mm,
TUNEL positive cells appeared only at 24, 48 and 72 h
post-SCI without significant differences from the sham con-
trol [43]. The significantly higher level of DNA fragmenta-
tion measured by ELISA in the injured cord relative to the
sham-operated cord was found even at 2 cm caudal from
the epicenter. This indicates a greater sensitivity of ELISA,
impossible by morphological observation of TUNEL-
positive cells at such distance. Clearly, morphological exam-
ination of TUNEL-positive and caspase-3-positive neurons,
motoneurons and astrocytes, and TEM identification are
feasible for characterized apoptosis in different types of cells
at the cellular level, whereas biochemical analysis of DNA
fragmentation and caspase activation has great value in de-
termining the spread of apoptosis from the epicenter. So
the results of biochemical analysis provide a great addition
to the morphological observation at longer distances from
the epicenter.
We previously demonstrated that MnTBAP (i.p.) sig-
nificantly reduced neuron death at sections 1–2.5 mm
rostral and 1 mm caudal from the epicenter [43]. The
present study demonstrated that antioxidant treatment
with a combination of MnTBAP + L-NA significantly re-
duced total cell and motoneuron loss in the gray matter
of the cord and glial cell loss in the ventromedial white
matter of the cord compared with vehicle-treated rats
(Figure 7). Significant increases in the number of glial
cells in the white matter by the combination treatment
was closer to the epicenter (at sections 0 – 1.0 mm from
the epicenter) compared with the increases of total cells
(at sections 1.5 – 2.5 mm from the epicenter) and moto-
neurons (at sections 2.0 and 2.5 mm from the epicenter)
in the gray matter. This is owing to the fact that mostcells near the epicenter in the gray matter of the cord
have been lost and cannot benefit from the treatment,
whereas the glial loss was much slighter in the ventral
white matter, so that many glia are still alive even in the
epicenter, to be counted to evaluate the effectiveness of
the treatment. Attenuation of total cell and motoneuron
loss by the combination suggests that RS contribute to
cell death after SCI.
We previously demonstrated that MnTBAP (i.p.) sig-
nificantly reduced the TUNEL-positive neurons at 1 mm
caudal from the epicenter [43]. In the present study, we
demonstrated that the combination of MnTBAP + L-NA
significantly reduced the numbers of TUNEL-positive
cells in the gray and white matter of the cord as com-
pared with the vehicle treatment: an approximately 2.4
times reduction in the gray matter and approximately 10
times reduction in the white matter (Figure 8). The more
effective reduction of TUNEL-positive cells in white
matter compared with those in gray matter might be at-
tributable to the much slighter cell loss in the ventral
white matter as shown in Figure 7. We further demon-
strated that MnTBAP alone (i.p.) significantly reduced
the number of TUNEL-positive cells in the gray matter
of the cord at sections 0, 1 and 2 mm rostral from the
epicenter, with the number of TUNEL-positive cells in
the vehicle-treated sections approximately 3, 2 and 2.5
times higher than those in the corresponding sections in
the MnTBAP-treated group (Figure 9). The reports that
treatment with antioxidants, RS scavengers and iron-
chelators all reduce RS production, oxidative stress and
apoptotic cell death after SCI links RS with apoptotic
cell death in SCI [10-13,69,70,72-75]. The impressive re-
duction in apoptosis by MnTBAP or its combination
found in this study strongly supports the notion of the
correlation of RS overproduction and apoptosis in SCI
and provides further evidence of the causal relationship
between RS overproduction and necrotic and apoptotic
cell losses. The present results ― together with our pre-
vious finding that the combination or MnTBAP alone
significantly reduces oxidation and nitration of proteins
and MLP, cell death, and neurological deficits after SCI
in rats [18,21,38-40,43] ― support the sequence RS →
oxidative stress → cell death → neuronal dysfunction.
Using behavioral tests, we recently reported that, with
its lower ability than MP to penetrate the BSB, 10 mg/kg
MnTBAP administered (i.p.) 4 h post-SCI followed by
one half of the first dose 2 h later significantly increased
BBB and inclined plane scores compared to vehicle
treatment. Post-SCI treatment with MnTBAP is signifi-
cantly more effective than MP for improving functional
recovery after SCI [40]. In the present study, we demon-
strated that 15 min pre- and 6 h post-SCI treatment with
MnTBAP significantly increased the scores of BBB and
beam walk tests, and increased the angle of inclined
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pre- and post-SCI treatment by MnTBAP strongly sup-
port the candidacy of MnTBAP for SCI treatment. How-
ever, the scores for all treatments in injured animals
were significantly worse compared to sham controls (p <
0.001 for all), indicating that pharmaceutical treatments
alone cannot improve function to normal levels.
The BBB test is a standard behavioral test for estimating
the time course of recovery after SCI and for evaluating the
efficiency of treatment. An injury force of 25 g.cm (10 g
weight drop 2.5 cm down onto the exposed cord) was
popularly used for the contusion injury, and the BBB scores
of rats corresponding to this injury force are from 0 to 6 –
10 overtime [6,13,51]. In the present study, the contusion
force was 12.5 g.cm and the BBB scores of rats were from 0
to approximately 15 overtime. A similar BBB scores (0 to
approximately 14) was reported by Hyun et al. [63] using
the 12.5 g.cm injury force on T9. Using the IH device,
Springer et al. [54] reported that a 150 kilodyne injury force
(which gives an injury comparable to that produced by a
12.5 g.cm weight drop with the NYU device) contused on
T10, produced BBB scores of 0 to 12. Apparently, the BBB
scores are correlated with the injury force and our results
are comparable with other reports with similar injury force.
This is also supported by our recent publication in which a
12.5 g.cm injury force was used on T10 [40].
We have demonstrated in vivo that RS administered into
an uninjured rat spinal cord at a SCI-induced concentration
and duration can directly oxidize major cellular compo-
nents, thereby inducing necrotic and apoptotic cell death
and neurological deficits, and that the removal of RS by
MnTBAP significantly reduces the RS-induced damage
[27-31] - directly and unequivocally demonstrating RS-
induced oxidation to the major cellular components as
an important pathway for cell death after SCI. Since the
oxidative defense enzymes (such as superoxide dismutase,
catalase, glutathione peroxidase, thioredoxin and others)
are all susceptible to RS-induced oxidative damage, they
may suffer function-distorting oxidative modification, in
turn causing more RS production to form a negative feed-
back amplification of the oxidative damage. MnTBAP
scavenges SCI-induced RS, protecting against oxidative
damage to these enzymes and thereby restoring their en-
zymatic activities. This process reverses the negative to
positive feedback amplification. RS can also cause injury
by acting as intracellular death signals that lead to changes
in the expression of proteins. RS may be active in different
cell death pathways, including the caspase activation cas-
cade. Therefore the removal of RS by MnTBAP reduces
apoptotic cell death. RS can also act as modulators of the
redox state, and the right dose of MnTBAP treatment to
remove overproduced RS helps to maintain the redox
balance, thereby avoiding further damage. Whether RS
are the initiators or the intracellular messengers in celldeath pathways after CNS injury, MnTBAP provides an
opportunity for treatment by removing RS. In addition
to catalytically scavenging a wide range of RS, other
mechanisms may also contribute to the beneficial effects
of metalloporphyrins, such as modulating RS-based
redox signaling pathways and regulating cellular tran-
scription activity [33]. It has been reported that
MnTBAP attenuated the nuclear translocation of
apoptosis-inducing factor and the subsequent DNA
fragmentation induced by ROS after permanent focal
cerebral ischemia in mice [76]. Therefore, in addition to
its enzymatic catalytic scavenging activities, more com-
plicated mechanisms may be involved in our in vivo
finding that MnTBAP reduced cell death including
apoptosis and improved functional recovery after SCI.
Conclusion
1) By counting the surviving cells in the spinal cord sec-
tions at the distances of 0 to 4 mm caudal from the epi-
center and at different times from 1 h to 1 week post-
SCI, the present study established the temporal and
spatial profiles of motoneuron and glial cell loss follow-
ing a severe experimental SCI (50 g.cm) at the lumbar
enlargement area. The loss of both motoneuron and glial
cells is time- and distance-dependent. The number of sur-
viving motoneurons decreased over time and increased
over distance from the epicenter. In contrast, glia loss in
the ventral white matter is much slighter and more limited
at the epicenter and quickly offset over time by prolife-
ration. Our three dimensional profiles of the different
types of cell loss provide a database for determining the
effective time and location of therapeutic intervention. 2)
By counting surviving cells in the spinal cord sections at
the distances from 0 to 4 mm rostral from the epicenter,
the present study established the spatial profiles of
MnTBAP + L-NA protection against different types of cell
loss at the lumbar enlargement area following SCI.
MnTBAP + L-NA significantly increased the number of
surviving cells at 1.5 – 2.5 mm, surviving motoneurons at
2 and 2.5 mm in the gray matter, and surviving glial cells
at 0 – 1 mm in the white matter rostral from the epi-
center. The effectiveness of this combination treatment
links cell death with SCI-induced RS elevation. 3) Apop-
tosis of neurons, motoneurons and astrocytes was charac-
terized in injured spinal cord sections morphologically by
double immuno-staining and double immuno-fluorescence-
staining with TUNEL or active caspase-3 + specific cell
markers. Neuronal and glial apoptosis was confirmed by
TEM identification. Our results, consistent with other re-
ports, suggest that apoptosis is a common mechanism for
different types of cell death after SCI. Using DNA ladder-
ing, ELISA and caspase-3 activation in spinal cord tissue
at different distances from the epicenter, we demonstrated
that apoptotic DNA fragmentation and caspase-3
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ELISA quantitation indicated that significant DNA frag-
mentation in the injured cords extended over 2 cm caudal
to the epicenter compared with the sham control cords. 4)
By counting TUNEL-positive cells in the spinal cord sec-
tions, we explored the protective ability of both MnTBAP
alone and its combination with L-NA against apoptotic
cell death after SCI. MnTBAP + L-NA significantly re-
duced the number of TUNEL-positive cells with an ap-
proximately 2.4-fold reduction in the ventral gray matter
and an approximately 10-fold reduction in the ventral
white matter. The combination seems more effective in
reducing the number of TUNEL-positive cells than in in-
creasing the number of surviving cells. MnTBAP alone sig-
nificantly reduced the number of TUNEL-positive cells at
0, 1 and 2 mm rostral from the epicenter to approximately
3, 2 and 2.5 times lower than in corresponding sections of
the vehicle-treated group. 5) MnTBAP protection against
neurological deficits was evaluated by behavioral tests for
9 weeks. We demonstrated for the first time that 15 min
pre- and 4 h post-SCI treatment with MnTBAP (10 mg/kg,
i.p.) significantly increased the scores on BBB and beam
walk tests, and increased the angle of the inclined plane test
compared to vehicle-treated groups, demonstrating that
antioxidant therapy with MnTBAP significantly improved
functional recovery compared with vehicle treatment. This
is a most important criterion for determining the thera-
peutic potential of a candidate agent for SCI treatment.
Our demonstration that apoptotic cell death follows SCI
and that MnTBAP, alone or in combination, significantly
reduced apoptosis correlates SCI-induced apoptosis with
RS overproduction. It provides evidence that the generation
of RS during the secondary damage cascade after SCI is a
cardinal factor leading to secondary neuronal and glial
death, thereby causing neurological dysfunction. There-
fore, antioxidant therapy is likely to play an important role
in the future treatment of SCI. Our results suggest that
MnTBAP is a potential candidate for antioxidant the-
rapy following SCI.Abbreviations
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